KAMURAGrowth hormone axis / VISUAL FIELD GUIDE
Ipamorelin
Ipamorelin stimulates growth-hormone release. Its early pharmacology should not be mistaken for proof of adult longevity benefits.
01 / FOLLOW THE BIOLOGY
From signal to response.
Schematic explanation · not a measured treatment response
STEP 1 OF 3
Receptor signal
A secretagogue prompts hormone release.
Pathway sources: [1]
What are you trying to understand?
Choose a concern to see the research context. A symptom is a starting point for assessment, not a treatment selection.
Preclinical pharmacology
Growth-hormone release
The foundational study examined GH secretion in cells, rats and swine.
Examine the supporting research ↓The details that change the interpretation.
Formulation & route
The foundational animal pharmacology does not validate a compounded human regimen.
Bring to the discussion
What patient outcome has been tested beyond a GH measurement?
Go beyond the summary.
More research already linked in Kamura (1)
Ipamorelin, the first selective growth hormone secretagogue. · 1998